3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Breast Neoplasms
545
Lymphoma
444
Precursor Cell Lymphoblastic Leukemia-Lymphoma
409
Lymphoma, Large B-Cell, Diffuse
347
Leukemia
344
Multiple Myeloma
335
Lymphoma, Non-Hodgkin
316
Leukemia, Myeloid, Acute
288
Leukemia, Lymphocytic, Chronic, B-Cell
285
Lymphoma, Follicular
240
Burkitt Lymphoma
217
Myelodysplastic Syndromes
209
Lymphoma, Mantle-Cell
201
Hodgkin Disease
193
Recurrence
153
Lymphoma, B-Cell, Marginal Zone
142
Melanoma
135
Lymphoma, Large-Cell, Immunoblastic
116
Neoplasms
109
Lymphoma, B-Cell
103
Neuroblastoma
101
Neoplasms, Plasma Cell
99
Ovarian Neoplasms
96
Triple Negative Breast Neoplasms
93
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
91
Myeloproliferative Disorders
87
Hematologic Neoplasms
87
Leukemia, Myeloid, Chronic-Phase
83
Leukemia, Myeloid, Accelerated Phase
80
Leukemia, Myelomonocytic, Chronic
78
Interventions
Specimen Handling
8
Paclitaxel
7
Magnetic Resonance Spectroscopy
6
Carboplatin
6
Biopsy
6
Nivolumab
5
pembrolizumab
3
olaparib
3
X-Rays
3
durvalumab
2
ceralasertib
2
cediranib
2
Taxes
2
Immunoglobulin G
2
trastuzumab deruxtecan
1
sargramostim
1
rucaparib
1
ribociclib
1
rebastinib
1
pelcitoclax
1
pazopanib
1
pamiparib
1
liposomal doxorubicin
1
cobimetinib
1
capivasertib
1
cabozantinib
1
belinostat
1
atezolizumab
1
apatinib
1
Trabectedin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Carcinosarcoma
×
Cyclophosphamide
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled